|
|
 |
|
|
 |
|
|
| |
|
Oct.
25, 2006 |
| |
|
Welcome to ACAAI eNews — a bi-weekly
aggregated
news service
from the American College of Allergy, Asthma & Immunology. To be
removed from this distribution list, please see instructions at
bottom. |
| |
 |
Top
Stories |
|
|
|
 |
Distance Learning |
|
|
|
 |
Drugs and Devices |
|
|
|
 |
Association
News |
| |
|
 |
Fellows-in-Training |
| |
|
 |
Calendar |
| |
|
 |
Archive |
|
|
|
|
 |
FIT Archive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distance Learning |
2005 Board/Recertification Review Course:
DVDs, Audio CDs, MP3s
Link
ACAAI Tape Store Complete Listing
Link
2005 ACAAI ANNUAL MEETING
• Symposia Online
Nov. 4-9, Anaheim
Link
2004 ACAAI ANNUAL MEETING
• Symposia Online
Nov. 12-17, Boston
Link
2003 ACAAI ANNUAL MEETING
Nov. 7-12, 2003, New Orleans • Two Symposia Online
Link
• Plenary Sessions CD-ROM and DVD
Link
Patient-Centered Allergy Practice Endorsed by ACAAI, Sponsored by Physicians Practice
Link
|
Calendar |
|
NOVEMBER
ACAAI XII International Food Allergy Symposium
Nov. 9, Philadelphia
ACAAI Annual Meeting
Nov. 9-15, Philadelphia
Tel: 847-427-1200
E-mail
Link
DECEMBER
International Congress on Exacerbations of Airway Disease
Dec. 8-10, San Juan, Puerto Rico
Tel: 212-988-7732
E-mail
Link
ONGOING
World Allergy Organization Society Meetings
ACAAI CME Website
Contact: Mary Campbell
Tel: 847-427-1200
E-mail
|
Sponsored
By |
 |
|
|
|
|
|
|
|
|
| |
Top
Stories |
| |
At-birth lung function may be
asthma predictor
Infants who perform poorly on lung function tests at birth
may be more likely to develop asthma before they are 10 years
old, according to a study in the New England Journal of
Medicine. Scientists at Ulleval University Hospital in Oslo,
Norway, enrolled 616 10-year-olds who had received lung-function
tests at birth. All were full-term infants who appeared healthy.
Each subject was evaluated for asthma via lung function tests,
blood samples and allergy testing. Parents reported that 20
percent of the children had a history of asthma and 11 percent
currently had asthma. Among the children with poorer lung
function tests at birth, more than 24 percent had a history of
asthma. Among the children who had normal lung function at
birth, about 16 percent had a history of asthma. Of the subjects
currently with asthma, 7.5 percent had normal lung function
tests at birth, vs. 14.6 percent who had poorer lung function
tests.

One-third of in-hospital asthma deaths among exacerbation
admissions
Up to one-third of all asthma deaths happen in patients
hospitalized for asthma exacerbations, according to a study in
the American Journal of Respiratory and Critical Care
Medicine. Scientists at the University of Chicago analyzed
65,381 hospital admissions for asthma exacerbation in patients
over 5 years old. The in-hospital asthma death rate was 0.5
percent. Of 4,487 deaths from asthma, 33 percent occurred in
patients hospitalized for asthma exacerbations. Researchers saw
no significant race differences in asthma exacerbation hospital
deaths.
Adverse drug reactions cause of 700,000 ED visits per year
Approximately 700,000 Americans per year have adverse reactions
to prescription drugs that require emergency department visits,
according to a study in the Journal of the American Medical
Association. Researchers at the Centers for Disease Control
and Prevention in Atlanta evaluated 21,298 adverse drug event
cases that were reported to a national surveillance system, from
Jan. 1, 2004, to Dec. 31, 2005. These results yielded weighted
annual estimates of 701,547 persons treated in emergency
departments for adverse drug reactions. Adverse drug events
included allergic reactions, unintended overdoses, adverse
effects, secondary effects, and vaccine reactions.
 |
|
|
A
message from President Dr. William Dolen
Kudos to Dr. John Yarbrough of Gainesville, Ga., who told
me last year how the iPod and video iPod would
revolutionize CME. I had never heard of podcasting, but
right after that I learned that the Medical College of
Georgia is planning to put most of our lectures in the
iPod's mp4 format over the next several years. I was still
skeptical until I actually saw a video iPod. The screen
resolution on the video device is absolutely amazing, and
skepticism quickly turned into lust. Imagine going to a
meeting, hearing a lecture, and having the slides (with
audio) automatically (or on demand) download to your
computer to review at your leisure. We have the
technology.
Please be patient with us as we work out the fine points
of podcasting a live medical meeting. For years, we've
been badgering speakers to produce legible slides, yet
every year we still have some idiot (sorry if I'm talking
about you) who will put 40 lines of light blue text on a
dark blue background and expect the audience to read
along. On the screen at a national meeting, it's
difficult. On the iPod — it will be absolutely illegible.
Ten lines of text, and no more, please. There could also
be audio glitches at the beginning. We will want your
feedback, as well as your ideas for other opportunities
for podcasting.
Profound thanks to the fine folks at GlaxoSmithKline who
have provided an educational grant to support production
of this initial series of podcasts. Supporting innovative
distance learning is going out on a limb in a big way, and
we appreciate their help.
(Disclosure: although your President has been a rabid
Macintosh user since 1984, he has no relationship with
Apple Computer, Inc.)
Best wishes,
Bill |
|
|
|
Drugs
and Devices |
|
|
Proventil to transition to
HFA propellant
Schering-Plough Corporation will begin Nov. 1 to transition
from its chlorofluorocarbon-containing albuterol asthma
inhalers distributed by its Warrick Pharmaceuticals division
to Proventil® HFA (albuterol sulfate), an albuterol inhaler
that delivers the same medicine with an environmentally
friendly propellant, hydrofluoroalkane. The company is
complying with the Montreal Protocol and its requirement to
remove ozone-depleting substances. Warrick Pharmaceuticals
plans to cease manufacturing CFC inhalers in early 2007.

FDA approves ciclesonide nasal spray
The U.S. Food and Drug Administration recently approved of
Omnaris (ciclesonide) nasal spray, a new drug for the
treatment of nasal symptoms associated with allergic rhinitis
in adults and children, 12 years and older. Omnaris is a
corticosteroid. The drug’s most common side effects in
clinical studies were headache, nosebleeds, and inflammation
of the nose and throat linings. Omnaris is manufactured by
ALTANA Pharma US Inc. of Florham Park, N.J.
 |
|
|
Association
News |
| |
|
Final Program
for the ACAAI Annual Meeting now online
Plan your itinerary for the Nov. 9-15 ACAAI Annual Meeting
using the complete Final Program now available
online.
Scan
the scientific program for up-to-date sessions and speakers.
Select the workshops and Meet the Professor Breakfasts
tailored to your needs. Note which concurrent sessions and
poster presentations you don’t want to miss. Jot down the
social events in your calendar and make those last-minute tour
reservations.
Order your tickets today for the Sunday evening, Nov. 12,
Annual Fundraising Dinner with Peter Nero and the Philly Pops.
Online registration is closed, but it’s not too late to
register in advance so your package will be ready to pick-up
at Registration. Downloadable Meeting Registration Forms also
are online for faxing.
For more information, contact ACAAI by e-mail:
meetings@acaai.org, by
telephone: (847) 427-1200, or fax: (847) 427-1294.
Symposium impacted by extended release
of new asthma
guidelines
An extended release date for the new NAEPP Asthma Guidelines
has resulted in changes in the Sunday, Nov. 12, 3:30 to 5:30
p.m. symposium.
“Like everyone else, I was looking forward to a first look at
the long-awaited update to the NAEPP Asthma Guidelines," says
Dr. Jay Portnoy, chair of the Pharmaceutical Symposium
Committee. “Though
the symposium won’t have specific information from the new
guidelines, it will have a stellar faculty to discuss issues
related to the use and implementation of Guidelines and to
discuss what they anticipate the new document will, and won’t,
address. This should lead to a fascinating preview of what is
to come.”
The featured symposium, “Controversial Issues Involving Asthma
Disease Management: Implications for Asthma Guidelines,”
moderated by Dr. Michael B. Foggs, will include the following
presentations:
What the Guidelines Didn’t Say
—
Dr. Thomas A.E. Platts-Mills
Controversies in Beta-agonist Therapy: Implications for
Evidence-Based — Asthma Guidelines Dr. John Oppenheimer
Implementing Asthma Guidelines Emphasizing Evidence-Based
Parameters —
Dr. Sheldon L. Spector
Upon completion of this session, participants should be able
to: 1) describe the limits of the guidelines; 2) recognize the
importance of variability of response to treatment of asthma;
3) evaluate the role of allergies in asthma; 4) implement
practical aspects of guidelines; and 5) discuss concepts from
guidelines.
Win a free 30 GB Video iPod at the ACAAI Annual Meeting
Doctors and allied health professionals who register for the
Annual Meeting will be given a raffle ticket in their
registration packets for a chance
to win one of 10 30 GB video iPods. The ticket must be
deposited into a collection box in the Exhibit Hall to qualify
for the drawing and participants must be present to win.
The drawings will be held 10:20 a.m., 12:20 p.m., and 3:20
p.m. on Monday in the back of Exhibit Hall D. Three iPod
winners will be drawn during each of the two breaks, and four
at lunch time.
Annual Meeting programs will be available as video podcasts
The College announces a new initiative to electronically
deliver scientific presentations from this year’s Annual
Meeting directly to its members as Vodcasts (video podcasts)
beginning in November.
Bi-weekly, members can view or download 30-minute Vodcasts of
key sessions to their computers or portable media players.
Users can retrieve files manually from the College Web site or
subscribe at no cost to a feed that automatically downloads
Vodcasts each time a new presentation is posted.
The first Vodcasts will contain the slides and audio from this
year’s Food Allergy Symposium and Literature Review Course.
Other key scientific sessions and non-meeting related material
also will be broadcast throughout the year.
Watch for more information about this new and exciting service
sponsored by an education grant from GlaxoSmithKline.
Online registration now open for the Board Review Course
Register
online for the ACAAI/AAAAI Certification/Maintenance
of Certification Board Review Course, April 19-22, 2007, at
the Renaissance Hotel in Chicago.
The Allergy and Immunology Review Course 2007 is developed and
presented by a conjoint committee appointed by ACAAI and AAAAI.
As ABAI is the certifying organization for the specialty — and
separate from these educational organizations — ABAI Directors
responsible for preparing the 2007 ABAI examinations are not
involved with the course presentations. Content outlines for
the examination are available on the
ABAI Web site.
The Conjoint Planning Committee includes Drs. Emil J. Bardana
Jr. (co-chair), Dennis Ledford (co-chair), Thomas A. Fleisher,
David A. Khan, Phillip Lieberman, Kathleen R. May, Dennis R.
Ownby, and William T. Shearer.
Board Review Course programs have been mailed to all College
and AAAAI members.
Look for your copy of the flu vaccination pocket guide
The 2006-07 Influenza Vaccination Pocket Information Guide has
been mailed with your copy of ACAAI News.
The handy quick reference card includes the following:
• Indications
• Contraindications and precautions
• Vaccine dosing and administration
• Side effects
• Talking points with patients
The Immunization Action Coalition (www.immunize.org)
created the cards in collaboration with the National Influenza
Vaccine Summit.
Patient information “Flu Vaccine and Egg Allergy” online
New patient education information about “Flu Vaccine and Egg
Allergy,” developed by the College’s Public Education
Committee and the Drugs and Anaphylaxis Committee, is
available
online.
“Patients with egg allergy should understand the risks
associated with some flu vaccines,” said Dr. A. M. Aminian,
Public Education Committee chair. “They also should be
informed that allergists have expertise to administer the
vaccine even for some people with egg allergy, which is
especially important for those with respiratory or age-related
risk factors attributed to complications caused by influenza.” |
|
|
Fellows-in-Training |
| |
|
Immunology Review Corner
Welcome to the Board Review Corner prepared by Karla R.
Davis, M.D., Senior Representative of ACAAI’s
fellows-in-training (FITs) to the Board of Regents. The Board
Review Corner is your chance to test your Board preparedness.
To refer to a previous Board Review Corner, click the “Archive”
link in the left column.
Immunology Review Corner: Chapter 80 of the 6th edition
of Middleton’s Allergy Principles and Practice, edited by
N. Franklin Adkinson, et al. Review questions were written by
Drs. Karla R. Davis, Landstuhl Regional Medical Center in
Germany, and Soo Kim-Delio, Walter Reed Army Medical Center.
 |
|
|
Copyright
© 2006 American College of Allergy, Asthma & Immunology. All
rights reserved.
E-newsletter services provided by the medical editors at Ascend
Media, LLC.
Do you have news, responses or opinions to share with us? Please
e-mail the association office at
enews@acaai.org.
THIS E-MAIL WAS SENT FROM A “SEND-ONLY” MAILBOX. Please DO NOT REPLY
to this e-mail. |
|
ACAAI eNews is sent as a membership benefit of the American
College of Allergy, Asthma & Immunology. If you would prefer not
to receive future issues and want to remove your name from our
mailing list, please
-click here- |
|
|
|
|
|
|
|
|